IR情報

2020/08/26~2021/01/22

IR情報&株価推移

日付始値高値安値終値前日比出来高時価総額25日乖離
2021
01/224,4004,4274,3744,413-1.14%567,9002兆4617億-0.16%
01/214,4674,5584,4594,464-0.09%814,8002兆4901億+0.97%
01/204,4574,4774,4274,468+0.25%606,3002兆4924億+1.06%
01/194,4294,4784,3974,457+0.84%544,5002兆4862億+0.84%
01/184,4124,4304,3924,420+0.14%486,6002兆4656億+0.07%
01/154,3944,4344,3694,414-0.16%637,5002兆4622億-0.07%
01/144,3674,4454,3554,421+0.89%853,3002兆4661億+0.18%
01/134,3744,3924,3214,382-0.45%842,2002兆4444億-0.68%
01/124,3634,4174,3354,402-0.07%717,9002兆4555億-0.23%
01/084,3414,4114,3144,405+1.92%986,8002兆4572億-0.09%
01/074,3774,3934,3044,322-0.16%1,247,5002兆4109億-1.91%
01/064,2794,3344,2604,329+1.41%545,8002兆4148億-1.73%
01/054,3444,3574,2614,269-1.11%577,5002兆3814億-3%
01/044,4024,4044,3004,317-2.29%522,9002兆4081億-2.02%
2020
12/304,4934,4934,4184,418-1.71%555,4002兆4645億+0.2%
12/294,4174,4974,4044,495+0.47%855,9002兆5074億+1.95%
12/284,5024,5224,4614,474+0.04%904,2002兆4957億+1.57%
12/254,4964,5024,4684,472+0.25%492,4002兆4946億+1.66%
12/244,4654,4894,4554,4610%463,5002兆4885億+1.55%
12/234,4814,4854,4504,461+0.41%542,6002兆4885億+1.71%
12/224,4574,4954,4394,443-1.27%673,9002兆4784億+1.44%
12/214,4914,5004,4444,500+0.47%591,0002兆5102億+2.93%
12/184,4054,4854,4044,479+1.52%1,033,9002兆4985億+2.68%
12/174,4004,4444,3894,412+0.11%565,0002兆4611億+1.24%
12/164,4614,4774,4034,407-0.38%713,6002兆4583億+1.19%
12/154,4894,4994,4154,424-1.23%599,8002兆4678億+1.68%
12/144,4484,5124,4404,479+1.22%798,1002兆4985億+3.16%
12/114,4024,4374,3824,425+0.55%955,9002兆4684億+2.19%
12/1015:00 超音波腎デナベーションシステム治療抵抗性高血圧に対する2つの国際共同臨床試験結果および米国FDAによるブレークスルーデバイス指定について
12/104,3854,4064,3724,401-0.16%713,8002兆4550億+1.88%
12/094,3504,4144,3354,408+1.8%763,5002兆4589億+2.32%
12/084,3554,3554,3194,330-1.52%657,2002兆4154億+0.91%
12/074,4064,4224,3774,397+0.66%459,2002兆4528億+2.93%
12/044,3584,4024,3494,368+0.69%667,0002兆4366億+2.63%
12/034,3034,3704,2974,338+0.35%795,2002兆4198億+2.26%
12/024,2974,3364,2784,323+0.7%1,058,6002兆4115億+2.2%
12/014,3124,3184,2274,293+1.2%1,056,0002兆3947億+1.75%
11/304,3934,4014,1964,242-3.42%2,205,4002兆3663億+0.76%
11/274,3934,4184,3464,3920%1,274,1002兆4500億+4.52%
11/264,3704,3924,3314,392-0.25%918,7002兆4500億+4.77%
11/254,4444,4474,4004,403+0.18%932,6002兆4561億+5.33%
11/244,3674,4434,3574,395+1.62%1,146,3002兆4516億+5.4%
11/204,2844,3254,2804,325+0.05%659,2002兆4126億+4.07%
11/194,2644,3234,2444,323+0.65%1,025,6002兆4115億+4.27%
11/184,3504,3584,2654,295-0.21%1,021,6002兆3959億+3.74%
11/174,2604,3244,2374,304+1.68%1,214,5002兆4009億+4.06%
11/164,2444,2804,2094,233-0.91%1,333,3002兆3613億+2.42%
11/1313:00 2020年12月期第3四半期決算短信〔IFRS〕(連結)
11/134,3384,3664,2554,272-2.47%1,248,4002兆3830億+3.36%
11/124,3364,3964,3184,380+0.99%1,264,6002兆4433億+5.93%
11/114,3984,4024,3254,337+0.93%1,165,2002兆4193億+4.96%
11/104,3234,3464,2624,297+2.43%1,201,5002兆3970億+3.97%
11/094,2054,2114,1714,195+0.31%832,2002兆3401億+1.48%
11/064,1204,1924,0974,182-0.12%841,0002兆3328億+1.06%
11/054,1394,1974,1014,187+2.37%1,228,8002兆3356億+0.94%
11/044,0914,1144,0284,090+2.51%1,050,4002兆2815億-1.8%
11/023,9194,0043,9183,990+3.5%768,1002兆2257億-4.66%
10/303,9503,9523,8483,855-3.19%1,252,1002兆1504億-8.35%
10/293,9484,0133,9143,982-0.8%788,4002兆2213億-5.89%
10/284,0264,0444,0044,014-0.82%832,9002兆2391億-5.58%
10/274,0714,0744,0324,047-0.15%485,9002兆2575億-5.22%
10/264,0734,1014,0424,053-0.42%316,5002兆2609億-5.46%
10/234,0674,0934,0434,070+0.84%541,3002兆2703億-5.41%
10/224,0924,0954,0304,036-2.46%769,5002兆2514億-6.6%
10/214,1314,1624,1204,138+0.71%507,9002兆3083億-4.72%
10/204,1114,1504,0994,109-0.58%642,6002兆2921億-5.74%
10/194,0794,1504,0774,133+2.23%538,5002兆3055億-5.53%
10/164,0444,0624,0214,043-0.86%737,1002兆2553億-7.86%
10/154,1524,1694,0724,078-2.58%894,6002兆2748億-7.44%
10/144,1774,1944,1514,186-0.21%694,1002兆3350億-5.34%
10/134,2204,2234,1664,195-0.92%601,0002兆3401億-5.3%
10/124,2284,2654,2094,234+0.09%623,4002兆3618億-4.79%
10/094,3194,3194,2214,230-2.06%990,3002兆3596億-5.24%
10/084,3434,3534,3174,319+0.28%689,1002兆4092億-3.57%
10/074,3124,3344,2874,307-1.24%732,7002兆4025億-4.14%
10/064,3314,3664,3184,361+1.02%420,6002兆4327億-3.2%
10/054,3124,3954,2944,317+0.75%756,0002兆4081億-4.43%
10/024,4264,4404,2704,285-3.66%1,267,1002兆3903億-5.43%
09/304,6134,6244,4374,448-3.58%1,609,7002兆4812億-2.16%
09/294,5594,6364,5064,613+0.79%722,9002兆5732億+1.3%
09/284,5784,5904,4944,577+1.04%1,075,7002兆5532億+0.46%
09/2515:00 抗精神病薬「エビリファイ持続性水懸筋注用」双極I型障害の効能追加が承認
09/254,5134,5434,4904,530+1.34%903,6002兆5269億-0.61%
09/244,4664,4854,4444,470-0.29%633,2002兆4935億-2.1%
09/234,4504,4974,4364,483+0.09%832,2002兆5007億-2.03%
09/184,4504,4884,4454,479+0.07%891,4002兆4985億-2.33%
09/174,4614,4844,4494,476+0.61%441,3002兆4968億-2.65%
09/164,4904,4934,4404,449-1.55%847,2002兆4818億-3.49%
09/154,5654,5714,4974,519-1.46%685,7002兆5208億-2.23%
09/144,5644,6104,5474,586+1.04%533,9002兆5582億-0.99%
09/114,5324,5454,4154,539+0.53%1,107,7002兆5320億-2.01%
09/104,4984,5194,4794,515+1.39%716,8002兆5186億-2.5%
09/094,4334,4674,4124,453-1.33%806,3002兆4840億-3.86%
09/084,4774,5134,4444,513+1.32%578,1002兆5175億-2.65%
09/074,4164,4744,4144,454+1%573,3002兆4845億-3.88%
09/044,5174,5204,3984,410-4.34%1,435,7002兆4600億-4.75%
09/0320:15 腎性貧血治療薬「バダデュスタット」保存期慢性腎臓病におけるグローバルフェーズ3試験の結果速報について
09/034,6244,6434,6034,610-0.77%641,7002兆5716億-0.5%
09/024,6714,6904,6244,646+0.48%411,5002兆5917億+0.37%
09/014,6454,6654,6034,624-0.71%682,7002兆5794億0%
08/314,6504,6994,6254,657+0.8%648,1002兆5978億+0.82%
08/284,6924,7314,5534,620-0.62%893,7002兆5772億+0.15%
08/274,7004,7204,6404,649-0.24%368,9002兆5933億+0.85%
08/264,6104,6764,6004,660+0.04%645,0002兆5995億+1.15%